ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to ...
ARS as a commercial company. It was a year focused on building infrastructure, educating the market and learning as we ...
Good morning, and welcome to ARS Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I will now turn the ...
U.S. net product revenue of $17.5 million CVS Caremark proposal in final stages of approval process; definitive update ...
A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of ...
This year marks a 50th anniversary few of us are celebrating — the identification of a new illness (which has probably been around for thousands of years) — Lyme disease. This illness, caused by a ...
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union, ...
Lancaster Guardian on MSN
Anaphylaxis – would you know what to do?
By Lydia Scroggs, Head of Clinical Strategy & Policy at St John Ambulance As we head into warmer months, St John Ambulance ...
Wellbeing Magazine on MSN
What to include in your personal safety kit for everyday life
Most people associate safety kits with disasters: earthquakes, hurricanes, and extended power outages. The post What to ...
Detailed price information for Alk-Abello As B Shs New (AKBLF) from The Globe and Mail including charting and trades.
Indolent systemic mastocytosis (ISM) can cause life-disrupting symptoms. However, most people with the condition have a ...
Viatris Inc. (Nasdaq: VTRS) today announced its first-quarter 2026 financial results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results